Dana-Farber Cancer Institute: For Older Patients With Blood Cancer Taking Multiple Medications, Tool Links Use of Certain Medications to Risk of Frailty
August 11, 2022
August 11, 2022
BOSTON, Massachusetts, Aug. 11 (TNSjou) -- The Dana-Farber Cancer Institute issued the following news release on Aug. 10, 2022:
A new tool developed by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital outperforms conventional methods for predicting whether certain medications are likely to lead to frailty in older patients with blood cancers who are taking multiple medications, a study being published online today indicates.
The tool, ca . . .
A new tool developed by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital outperforms conventional methods for predicting whether certain medications are likely to lead to frailty in older patients with blood cancers who are taking multiple medications, a study being published online today indicates.
The tool, ca . . .